Rosuvastatin calcium and process for producing intermediate thereof
US-2024360086-A1 · Oct 31, 2024 · US
US9441209B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9441209-B2 |
| Application number | US-201514660229-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 17, 2015 |
| Priority date | Dec 21, 2012 |
| Publication date | Sep 13, 2016 |
| Grant date | Sep 13, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Recombinant microbial cells are disclosed herein that comprise (i) a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein, and (ii) a polyunsaturated fatty acid (PUFA) biosynthetic pathway. The down-regulation of the polynucleotide sequence encoding Sou2 sorbitol utilization protein can increase the lipid content of the microbial cells and/or decrease the total amount of sugar alcohols produced by the microbial cells. Also disclosed are methods of using the recombinant microbial cells to produce oil containing omega-3 polyunsaturated fatty acids such as EPA.
Opening claim text (preview).
What is claimed is: 1. A recombinant microbial cell comprising a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein selected from the group consisting of Aspergillus niger, Bifidobacterium dentium, Candida albicans, Candida dubliniensis, Candida orthopsilosis, Candida parapsilosis, Cordyceps militaris, Debaryomyces hansenii, Enterobacter hormaechei, Gaeumannomyces graminis, Glarea lozoyensis, Lodderomyces elongisporus, Magnaporthe oryzae, Metarhizium acridum, Metarhizium anisopliae, Mycobacterium smegmatis, Neurospora crassa, Neurospora tetrasperma, Paracoccidioides brasiliensis, Penicillium chrysogenum, Scheffersomyces stipitis, Uncinocarpus reesii, Verticillium dahliae , and Yarrowia lipolytica , wherein said down-regulation decreases the total amount of sugar alcohols produced by the microbial cell, as compared to a suitable control cell. 2. The recombinant microbial cell of claim 1 , wherein said down-regulation is due to a mutation of said endogenous polynucleotide sequence. 3. The recombinant microbial cell of claim 2 , wherein said mutation is selected from the group consisting of a substitution, deletion and insertion. 4. The recombinant microbial cell of claim 3 , wherein said mutation is a deletion that removes (i) one or more nucleotides from an open reading frame encoding said Sou2 sorbitol utilization protein, and/or (ii) one or more nucleotides of a non-protein-coding sequence located within 500 base pairs of the 5′-end of said open reading frame. 5. The recombinant microbial cell of claim 3 , wherein said mutation is an insertion that occurs within (i) an open reading frame encoding said Sou2 sorbitol utilization protein, or (ii) a non-protein-coding sequence located within 500 base pairs of the 5′-end of said open reading frame. 6. The recombinant microbial cell of claim 1 , wherein said sugar alcohols comprise arabitol or mannitol. 7. The recombinant microbial cell of claim 1 , wherein said microbial cell is an oleaginous yeast cell. 8. The recombinant microbial cell of claim 7 , wherein said oleaginous yeast is a Yarrowia lipolytica cell. 9. The recombinant microbial cell of claim 8 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:10. 10. The recombinant microbial cell of claim 8 , wherein said endogenous polynucleotide sequence comprises a nucleotide sequence that is at least 95% identical to SEQ ID NO:9. 11. The recombinant microbial cell of claim 1 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 90% identical to SEQ ID NO:10. 12. The recombinant microbial cell of claim 11 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:10. 13. The recombinant microbial cell of claim 12 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 98% identical to SEQ ID NO:10.
for yeasts other than Saccharomyces · CPC title
using catalysts, e.g. selective catalysts · CPC title
Sorbose reductase (1.1.1.289) · CPC title
acting on CH-OH groups as donors (1.1) · CPC title
acting on NADH or NADPH (1.6) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.